The most essential report on the IVD industry, this 1,500-plus page report has provided reliable estimates and real-world forecasts for the in vitro diagnostics industry for two decades.

Customer experience in the clinical diagnostics industry is increasingly a target for improving overall customer satisfaction and a potential opportunity for differentiation beyond product performance, service plans, and price. This Kalorama Information report is an essential tool to learn how the in vitro diagnostics industry is seen from the point of view of their customers. […]

Digital pathology is the technique of analyzing high-resolution digitally scanned histology images, which may then be analyzed using computational tools and algorithms.  Digital pathology is enabled in part by virtual microscopy, a method of capturing microscopic images and transmitting them over computer networks.  This allows independent viewing of images by large numbers of people in […]

Trended bi-weekly data from March 26 to June 15th, and monthly from July to December. New purchasers will receive all historical data from March to December. Click here to download a brochure and sample data. This clinical diagnostics COVID-19 lab impacts tracker is produced through a continuous survey of clinical lab professionals at hundreds of […]

Molecular Diagnostics could be said to be the most important part of in vitro diagnostics.  This is especially true in the wake of COVID-19.  Kalorama Information has, for many years, estimated the size of and forecasted the growth of the worldwide market for these important in vitro diagnostic tests in all major segments, and does […]

Kalorama Information’s report provides a comprehensive market analysis and business planning tool for the market for tests that are aligned with a pharmaceutical treatment.  Especially in oncology, companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers […]

In light of the COVID-19 (coronavirus) pandemic, it is extremely timely to present a report on the status quo in emerging infectious diseases. While the current pandemic is troublesome and has disrupted normal life, it will follow its course and then fade away.  Where could the next pandemic or epidemic come from?   There are a number […]

Kalorama Information’s Hematology and Coagulation Markets (Lab-based and Decentralized Markets) examines the current state of two growing testing markets. Hematology is the study of peripheral blood and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. The menu of hematology tests includes: CBC + 5-part differential […]

CLICK HERE TO VIEW NEW VERSION OF THIS REPORT The current COVID-19 crisis affecting the United States and the world has caused hundreds of thousands of deaths and countless economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the […]

Outsourcing drug discovery is the beginning phase of the drug development process. Through outsourcing portions of their drug discovery programs, many pharmaceutical and biotechnology companies have found an effective cost-cutting strategy that can also improve the hit-to-lead conversion and early identification of unsuccessful compounds. In view of the fact that outsourcing can accelerate the drug […]